Boot Camp Registration Open
Boot Camps sponsored by:
Our Events
23 - 26 Apr 2023
Boot Camps sponsored by:
Expanded Access, Named Patient, Compassionate Use… the names for the process are as varied as the options for supporting them. This interactive course will give an overview of expanded access as well as discuss relevant regulations and their impact on operational and strategic planning. Atttendees will be able to hear from subject matter experts with many years experience on best practices and important questions to ask when supporting these types of studies. Come to this boot camp to discuss the regulations for Expanded Access and how they impact your operational and strategic supply planning.
The class is designed for clinical supplies professional that want to learn more about the fundamentals of international logistics as well as build more specific knowledge on trade compliance, Value Added Tax (VAT) and best practices when planning and executing global clinical trials. This class will cover international shipping regulations, temperature control during extended transit, customs clearance, VAT strategies and how to maximize logistics supply chain partnerships to ensure success with international distribution.
This class, geared towards people new to the world of clinical trial supplies, focuses on drug development and what goes into planning for and delivering a study drug for a clinical trial. Topics include: reasons behind Good Manufacturing Practices (cGMPs), phases of new drug development and approval, randomizing and blinding clinical trial materials, quality assurance and documentation, protocol interpretation, patient compliance, labeling, standard operating procedures (SOPs), stability, Good Distribution Practices (GDPs), returned drug accountability, and changing regulations in the European Union (EU) and rest of world (ROW). Attendees will hear a massive amount of information in a fun and interactive atmosphere.
This class is geared towards people that have some experience in the clinical trial supplies world. Attendees will be provided with a quick overview and then will take a deeper dive into Interactive Response Technology (IRT). This will include the development path for IRTs; the stages of build, from creating the User Requirement Specification (URS) to quoting, coding, validation, user acceptance testing and go-live; the reasons to use an IRT as well as when NOT to use an IRT; build requirements, including randomization codes and med code IDs; ensuring modules are built to manage individual regulatory country approvals, shipping requests and returns and reconciliation; as well as timelines from concept development to system go-live.
Whether this is your first time attending or you are an 'old pro', plan to join us at the conference orientation to learn how you can make the most of your time at the GCSG 2023 Conference!
Sponsorsored by:
Anne Grady is a best-selling author, entrepreneur, and an expert in building resilient teams, leaders, and organizations. She is also a two-time TEDx speaker, trainer, survivor, optimist, and inspirer.
Anne has a master’s degree in organizational communication and has spent the last twenty years working with some of the largest organizations around the globe, including: Microsoft, Dell, Lockheed Martin, Johnson & Johnson, ADP, and Google. Anne is featured in press and media and contributes to Harvard Business Review, Entrepreneur, Fast Company, Inc. Magazine, FOX Business and more.
Anne is known for her ability to intertwine storytelling, neuroscience, and psychology with wit, humor, and authenticity. She shares inspiring personal stories, cutting edge, research-based content, and implementation tools to transfer learning into real life. And she’ll make you laugh while she does it.
In her first two books, Anne provides practical strategies to improve relationships, increase productivity, and reduce stress. Her latest book, Mind Over Moment: Harness the Power of Resilience, outlines a science-based approach to build a resilient mindset, skill set, and the ability to reset.
Anne is a mental health advocate and donates a portion of all book proceeds to the National Alliance on Mental Illness and was recently named as one of SUCCESS Magazine’s Best Motivational Speakers to Know in 2022.
Awareness of the regulatory requirements across different agencies is critical for being a successful CT Supplies professional. This workshop will discuss the regulatory requirements of West, Central and East Africa countries for labelling and distribution as well as how they impact CT supplies timelines and planning.
There are so many ways we can unblind our clinical trials. This workshop will discuss many of the different ways our clinical supply chain can contribute to unblinding. These can include differences in packaging configuration between arms in a trial, shipping to a clinical site with documents that could unblind the trial or IRT challenges that lead to unblinding.
How to transfer from Clinical Supply Chain in traditional Pharma to Cell Therapy Pharma. There are similarities, but many more differences such as extreme cold chain, label text differences, Chain of Custody/Chain of Identity Requirements, etc. This presentation will provide an overview of the similarities and differences as well as explain the exciting aspects of the cell therapy clinical supply chain.
New concepts and execution with decentralized trials have had a large impact on direct-to-patient distribution of clinical supplies. This workshop will discuss new concepts and different techniques being used to connect the best direct-to-patient strategy with new techniques in decentralized trials.
Comparator sourcing, a complex and challenging activity, is required to conduct the majority of clinical trials today. This workshop will prompt discussion around some of the key challenges and how to set yourself up for success when sourcing for global clinical trials.
IRT systems have been in use for over 20 years yet there is still functionality that users may be unaware of that can improve their chances of clinical supply chain success. This workshop will focus on industry best practices to improve the forecast of study enrollment using data analytics to positively impact the clinical supply chain.
Labeling clinical supplies is complex and varies depending upon what countries we are conducting studies in. This workshop will discuss what should go on the labels for all different clinical trial materials, where it should go and how to ensure the right language is being used at the site.
Awareness of the regulatory requirements across different agencies is critical for being a successful CT Supplies professional. This workshop will discuss the regulatory requirements of Latin American countries for labeling and distribution as well as how they impact CT supplies timelines and planning.
Now that the Clinical Trial Regulation is in place in Europe, what should we know, what should we be doing to comply with it and what are the timelines for compliance? This workshop will provide an opportunity to discuss requirements and ask questions from a QP perspective.
Pooling of supplies has been in use for a number of years. Recently, there has been a new strategy to use master protocols for pooling somewhat similar to program-level pooling but with a single protocol. The greatest challenge when using this strategy is to align the regulatory filing requirements for each of the sub-protocols. This workshop will explain how to achieve the greatest success when using this pooling strategy.
The number of temperature excursions our industry experiences is still too high. This workshop will provide a forum for discussing the latest innovation and technical solutions to control, track, trend and avoid temperature excursions for the life of the product. This workshop will also provide examples of systems in use that can decrease investigations, route case analysis and CAPA timelines for temperature excursions.
In this workshop we will discuss ways to increase the influence of clinical supplies to achieve the best outcomes, the shortest timelines and the fewest number of changes to the clinical supply chain by working closely with our partners in clinical operations.
Leaders from small biopharma companies help you understand the challenges of working in a small organization and competing with mid-size to large companies for manufacturing and packaging slots while still delivering against tight timelines.
The global reach of today's clinical trials makes understanding your product and its specific transit & import/export requirements a must for any clinical supply chain. This workshop will discuss ways to navigate the myriad of complex regulations involved in the import and export of clinical trial supplies, including valuation and harmonized system tariff codes.
One of the last things considered when executing the clinical supply strategy for clinical studies is the study closeout. This workshop will provide guidance for how to plan for and accomplish a study closeout that ensures the highest level of efficiency and cost-savings for the clinical supply chain. This could not be more important due to the focus on returns and reconciliation in the clinical trial regulation.
As stability testing and re-test dates are so critical to clinical supplies, this workshop will explore ways to improve oversight and understanding of stability protocols. We will also discuss the importance of building relationships with analytical to get timely updates for CofA's to positively impact CTM planning and forecasting.
An opportunity to talk about what our companies are doing (or what we'd like them to be doing) as it relates to increasing diversity, equity and inclusion (DEI) in hiring.
Post-pandemic our industry has experienced a tectonic shift in how we accomplish our mission and how we work together as teams. This workshop will provide a facilitated approach to produce tips and techniques to help leaders evolve and create high-performing teams, no matter where they are.
We all know it's hard for employees or even individual departments to influence corporate policy. Let's discuss ways that clinical supply professionals can have a greater impact on corporate sustainability.
Monday's meals sponsored by:
Enjoy a little treat after lunch with Liquid Nitrogen Ice Cream! Flash freezing ice cream reduces the size of ice crystals resulting in creamier tasting ice cream. Don’t miss out on a frozen treat!
Ice cream sponsored by:
Pooling of supplies has been in use for a number of years. Recently, there has been a new strategy to use master protocols for pooling somewhat similar to program-level pooling but with a single protocol. The greatest challenge when using this strategy is to align the regulatory filing requirements for each of the sub-protocols. This workshop will explain how to achieve the greatest success when using this pooling strategy.
In current times we are seeing a dramatic disconnect between the demand for clinical supplies staff and the available resource of talent. Consider the causative factors and explore winning solutions we can bring back to our organizations.
Blockchain is a type of distributed ledger, an expanding chronologically ordered list of cryptographically signed, irrevocable transactional records shared by all participants in a network. AI (Artificial Intelligence) or ML (Machine Learning) refers to software technologies that make a robot or computer act and think like a human. This workshop will explain what Blockchain and AI are and discuss how they are transitioning from theoretical concepts to how they are being implemented into the Clinical Supply Chain.
Under the Clinical Trial Regulation, Auxiliary Medicines have been categorized as Authorised and Unauthorised, and there are requirements that go along with each. What does the Regulation have to say about Auxiliary Medicines and how does that impact sponsors and how these are sourced and labelled? We also invite attendees to share different strategies they have used under the CTR for auxiliary medicines.
Awareness of the regulatory requirements across different agencies is critical for being a successful CT Supplies professional. This workshop will discuss the regulatory requirements of West, Central and East Africa countries for labelling and distribution as well as how they impact CT supplies timelines and planning.
In working to increase the use of DTP in clinical trials, the GCSG DTP subteam (under the Regulatory e-Team) sent out an industry survey. This workshop will review the findings, trends and possible directions forward to increase the adoption of DTP as a clinical supply distribution model.
This session provides a broad overview of the diverse mechanisms to support patients ability to access investigational drugs. In this workshop we will go over all these mechanisms which will enable you to successfully understand which is the best pathway based on the patient need. Topics covered will include compassionate use, off-label access, continued access, special license sales and right-to -try.
As the world of clinical supplies becomes increasingly complex, it is essential that Clinical Supply partners with Quality to achieve the best outcomes. An essential step in this process is to build a quality culture within the clinical supply unit while developing excellent relationships between the two groups. This session will discuss ways to build that culture and partnership within your own organization.
Get ready for one of the most incredible parties GCSG has ever thrown—a huge bash that fills three different clubs in Universal CityWalk at Universal Orlando Resort. Take a trip to New Orleans at Pat O’Brien’s®, explore the home of the king of reggae at Bob Marley—A Tribute to FreedomSM, and take the stage at CityWalk’s Rising Star nightclub. It’s an entire evening of excitement!
Sponsored by:
Get ready to celebrate with a huge party at Universal CityWalk. GCSG has reserved the Red Coconut Club just for you! Enjoy the trendy, tropical cool of Orlando’s hottest ultra-lounge where you can take in the view on the balcony, mellow out at intimate tables inside, or mix with lively crowds around the bars.
Sponsored by:
Katie Ortman Doble is a patient advocate, writer and motivational speaker who inspires through her witty and optimistic outlook as a stage 4, ocular melanoma survivor. Doble credits a mix of integrative healing, positive attitude, and Western medicine for allowing her to survive cancer for nine years and counting. Her blog, Future Happy Self, is part self-exploration about her own journey to finding health and happiness and part advice column so that others may learn from her experiences. Doble works as a headhunter in the Colorado market in addition to doing patient advocacy and public speaking.
In 2017, Doble was given the Courage Award from the Melanoma Research Foundation. In 2018, a 5-part series on living wills written by Doble was featured on the Denver Hospice blog and picked up by Denver’s local Fox affiliate. Doble was the 2021 recipient of First Descents' Out Living It Award.
Doble lives in Denver with her husband, Nick, whom she met after first connecting on LinkedIn, and their dog Alice. Thanks to ocular melanoma, Doble and Alice have matching heterochromatic eyes. The Doble family loves to hike, bike, cook and travel.
There are so many ways we can unblind our clinical trials. This workshop will discuss many of the different ways our clinical supply chain can contribute to unblinding. These can include differences in packaging configuration between arms in a trial, shipping to a clinical site with documents that could unblind the trial or IRT challenges that lead to unblinding.
Leaders from small biopharma companies help you understand the challenges of working in a small organization and competing with mid-size to large companies for manufacturing and packaging slots while still delivering against tight timelines.
In current times we are seeing a dramatic disconnect between the demand for clinical supplies staff and the available resource of talent. Consider the causative factors and explore winning solutions we can bring back to our organizations.
Under the Clinical Trial Regulation, Auxiliary Medicines have been categorized as Authorised and Unauthorised, and there are requirements that go along with each. What does the Regulation have to say about Auxiliary Medicines and how does that impact sponsors and how these are sourced and labelled? We also invite attendees to share different strategies they have used under the CTR for auxiliary medicines.
An opportunity to talk about what our companies are doing (or what we'd like them to be doing) as it relates to increasing diversity, equity and inclusion (DEI) in hiring.
New concepts and execution with decentralized trials have had a large impact on direct-to-patient distribution of clinical supplies. This workshop will discuss new concepts and different techniques being used to connect the best direct-to-patient strategy with new techniques in decentralized trials.
Post-pandemic our industry has experienced a tectonic shift in how we accomplish our mission and how we work together as teams. This workshop will provide a facilitated approach to produce tips and techniques to help leaders evolve and create high-performing teams, no matter where they are.
Now that the Clinical Trial Regulation is in place in Europe, what should we know, what should we be doing to comply with it and what are the timelines for compliance? This workshop will provide an opportunity to discuss requirements and ask questions from a QP perspective.
IRT systems have been in use for over 20 years yet there is still functionality that users may be unaware of that can improve their chances of clinical supply chain success. This workshop will focus on industry best practices to improve the forecast of study enrollment using data analytics to positively impact the clinical supply chain.
Autologous cell therapies are at the forefront of the cell and gene therapy revolution. Come to this workshop to contribute and learn about Vein to Vein activities, Considerations when setting up a Patient centric supply chain organization, identify resources early to support Chain of Identity / Chain of Custody, and how to manage distribution of these precious cells. If you have a hot topic, please bring it with you and we can utilize the knowledge of the room.
One of the last things considered when executing the clinical supply strategy for clinical studies is the study closeout. This workshop will provide guidance for how to plan for and accomplish a study closeout that ensures the highest level of efficiency and cost-savings for the clinical supply chain. This could not be more important due to the focus on returns and reconciliation in the clinical trial regulation.
Awareness of the regulatory requirements across different agencies is critical for being a successful CT Supplies professional. This workshop will discuss the regulatory requirements of Latin American countries for labeling and distribution as well as how they impact CT supplies timelines and planning.
Labeling clinical supplies is complex and varies depending upon what countries we are conducting studies in. This workshop will discuss what should go on the labels for all different clinical trial materials, where it should go and how to ensure the right language is being used at the site.
Comparator sourcing, a complex and challenging activity, is required to conduct the majority of clinical trials today. This workshop will prompt discussion around some of the key challenges and how to set yourself up for success when sourcing for global clinical trials.
Brief introduction to Abacus Medicines Pharma Services (AMPS)
In the pharmaceutical industry, efficient and accurate supply forecasting is crucial for ensuring timely and cost-effective production and distribution of IMP. This session will explore several use cases for 4C Supply®, a powerful tool for modeling study demand and forecasting drug supply, and how it can help stakeholders make better, more informed decisions.
This vendor showcase will discuss how 4C Supply® puts data visibility and scenario planning in the hands of clinical supply professionals, allowing them to have greater control over the production and distribution processes. By providing sponsors with the data they need to make informed decisions, 4C Supply® can help organizations streamline their supply chains and reduce costs while ensuring sufficient supplies for patient treatment.
Attendees will leave the presentation with a deeper understanding of the benefits of 4C Supply® and how it can help them improve their drug supply forecasting processes. They will also gain valuable insights into how to use data effectively to plan production and make better decisions in the face of challenging scenarios.
Learn how to harmonize your clinical and commercial supply chain to achieve quality assurance, development, and operational excellence. The head of clinical supply chain planning at Roche will share how they have reinvented and standardized their clinical processes to support new types of clinical trials and medicines giving them full visibility of their global supply chain status to proactively avoid shortages and waste.
This session provides a broad overview of the diverse mechanisms to support patients ability to access investigational drugs. In this workshop we will go over all these mechanisms which will enable you to successfully understand which is the best pathway based on the patient need. Topics covered will include compassionate use, off-label access, continued access, special license sales and right-to -try.
The number of temperature excursions our industry experiences is still too high. This workshop will provide a forum for discussing the latest innovation and technical solutions to control, track, trend and avoid temperature excursions for the life of the product. This workshop will also provide examples of systems in use that can decrease investigations, route case analysis and CAPA timelines for temperature excursions.
As the world of clinical supplies becomes increasingly complex, it is essential that Clinical Supply partners with Quality to achieve the best outcomes. An essential step in this process is to build a quality culture within the clinical supply unit while developing excellent relationships between the two groups. This session will discuss ways to build that culture and partnership within your own organization.
Blockchain is a type of distributed ledger, an expanding chronologically ordered list of cryptographically signed, irrevocable transactional records shared by all participants in a network. AI (Artificial Intelligence) or ML (Machine Learning) refers to software technologies that make a robot or computer act and think like a human. This workshop will explain what Blockchain and AI are and discuss how they are transitioning from theoretical concepts to how they are being implemented into the Clinical Supply Chain.
We all know it's hard for employees or even individual departments to influence corporate policy. Let's discuss ways that clinical supply professionals can have a greater impact on corporate sustainability.
In working to increase the use of DTP in clinical trials, the GCSG DTP subteam (under the Regulatory e-Team) sent out an industry survey. This workshop will review the findings, trends and possible directions forward to increase the adoption of DTP as a clinical supply distribution model.
As stability testing and re-test dates are so critical to clinical supplies, this workshop will explore ways to improve oversight and understanding of stability protocols. We will also discuss the importance of building relationships with analytical to get timely updates for CofA's to positively impact CTM planning and forecasting.
The global reach of today's clinical trials makes understanding your product and its specific transit & import/export requirements a must for any clinical supply chain. This workshop will discuss ways to navigate the myriad of complex regulations involved in the import and export of clinical trial supplies, including valuation and harmonized system tariff codes.
In this workshop we will discuss ways to increase the influence of clinical supplies to achieve the best outcomes, the shortest timelines and the fewest number of changes to the clinical supply chain by working closely with our partners in clinical operations.
How to transfer from Clinical Supply Chain in traditional Pharma to Cell Therapy Pharma. There are similarities, but many more differences such as extreme cold chain, label text differences, Chain of Custody/Chain of Identity Requirements, etc. This presentation will provide an overview of the similarities and differences as well as explain the exciting aspects of the cell therapy clinical supply chain.
As clinical storage and distribution complexities evolve rapidly, careful orchestration of all pieces of the pharmaceutical journey, from clinical to commercial, is critical to remain resilient against unpredictable challenges and global disruptions. A patient-centric supply chain strategy that includes a single-source ready-now network with the right people in the right locations powered by the right technology provides the ability to be proactive and agile amid ongoing clinical trial transformation.
Our presenters are Mark Newman and Abigail French. Both are Business Development Directors.
An interactive workshop where we will go into details and best practices on how you can utilize your IRT functionality to improve your clinical trials supply management. This session will include an overview of how to utilized IRT to make better informed decisions about your demand & supply plan. We will also review important IRT settings for creating the user specifications, how they impact your demand & supply plan, and common pitfalls and ways to solve them in supply forecasting.
Everyone in clinical supplies knows we work in a complex and highly regulated space. One of our biggest challenges is that our scientific and technical advances can move faster than the competent authorities.
Please join us for a multinational panel composed of members from our very own GCSG Regulatory eTeam, who will share their updates and insights on the changing regulations that guide our industry.
The panel will provide an opportunity for conference attendees to ask their regulatory questions and provide an open forum to share knowledge and discuss issues.
Join GCSG to gain full access to our educational resources and our member directory of more than 600 clinical supply colleagues!